Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.20%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +35.84%
#5 RedStone RedStone +30.12%
#6 Humanity Humanity +25.83%
#7 Codatta Codatta +22.98%
#8 Walrus Walrus +19.40%
#9 Enso Enso +18.53%
#10 The Black Bull The Black Bull +18.16%
Coin of the day
EXOD EXOD
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.

Jupiter Neurosciences, Inc.

JUNS
Clasificación en acciones #36527
Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in... Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damages the nervous system and causes mobility issues. Also in Phase II, JNS102 is being developed for mucopolysaccharidosis Type I, JNS107 for MELAS Syndrome, and JNS108 for mild cognitive impairment and early Alzheimer's disease. Furthermore, the company is progressing JNS109 for amyotrophic lateral sclerosis, JNS110 for traumatic brain injury and concussion, and JNS120 as a treatment for COVID-19. Founded in 2016, the company, formerly known as Jupiter Orphan Therapeutics, Inc., adopted its current name in August 2021 and is headquartered in Jupiter, Florida.
Precio por acción
$5.34
Última sincronización: 2026-08-14
Capitalización bursátil
$2.59M
Cambio (1 día)
-11.00%
Cambio (1 año)
313.95%
País
US
Comercio Jupiter Neurosciences, Inc. (JUNS)

Categoría

Healthcare
Historial del precio de la acción de Jupiter Neurosciences, Inc. (JUNS)
Precio más alto de cierre: $4.45 el 2026-08-01

Precio más bajo de cierre: $10.06 el 2024-12-01
Historial del precio de la acción de Jupiter Neurosciences, Inc. desde 2024 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -20.40%
2025 -88.77%
2024 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE